US Broker Ratings

Ultragenyx Pharmaceutical Inc. (RARE) Stock Analysis: Exploring a 113% Upside Potential

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) stands as a noteworthy player in the biotechnology sector, focused on developing treatments for rare and ultra-rare genetic diseases. With a..

RadNet, Inc. (RDNT) Investor Outlook: A 40% Potential Upside in Healthcare Imaging

RadNet, Inc. (NASDAQ: RDNT), a prominent name in the healthcare sector, specifically in diagnostics and research, has been capturing investor attention with its substantial growth potential..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Exploring a 49% Upside Potential in the Biotech Sector

Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a notable player in the biotechnology sector, is drawing considerable attention from investors due to its promising pipeline of RNA-targeted therapeutics..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: A Look at Strong Analyst Ratings and Significant Growth Potential

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) stands at the intersection of hope and innovation in the biotechnology sector, focusing on therapeutic solutions for rare neuroendocrine diseases. With..

Teleflex Incorporated (TFX) Stock Analysis: Navigating a 32.3% Revenue Growth Amidst a Complex Valuation

Teleflex Incorporated (NYSE: TFX), a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry, has garnered significant attention from investors due..

Krystal Biotech, Inc. (KRYS) Stock Analysis: Exploring a Promising 12.70% Upside

Krystal Biotech, Inc. (NASDAQ: KRYS) has been making waves in the biotechnology sector with its innovative approach to tackling genetic diseases. As a commercial-stage company, Krystal..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Evaluating the Growth Potential Amid Robust Revenue Expansion

Halozyme Therapeutics, Inc. (NASDAQ: HALO) is making waves in the biotechnology sector, presenting significant opportunities for investors focused on innovative healthcare solutions. The company, headquartered in..

Bruker Corporation (BRKR) Stock Analysis: Navigating a 0.32% Dividend Yield Amidst a Mixed Performance Landscape

Bruker Corporation (NASDAQ: BRKR), renowned for its innovative advancements in scientific instruments and analytical solutions, stands as a notable player within the healthcare sector, specifically in..

BrightSpring Health Services (BTSG) Stock Analysis: 31% Upside Potential in the Healthcare Sector

BrightSpring Health Services, Inc. (BTSG) stands out in the healthcare industry, not only for its comprehensive services but also for its promising investment potential. With a..

Nuvalent, Inc. (NUVL) Stock Analysis: A $9.79 Billion Biotech Game-Changer Facing Analyst Consensus

Nuvalent, Inc. (NASDAQ: NUVL) is making waves in the biotechnology sector with its innovative approach to addressing treatment resistance in cancer therapies. With a market capitalization..

Elanco Animal Health (ELAN): Strong Buy Ratings and 14% Upside Potential

Elanco Animal Health Incorporated (NYSE: ELAN) is capturing investor attention with its robust position in the healthcare sector, specifically within the drug manufacturing industry for specialty..

Bausch + Lomb Corporation (BLCO) Investor Outlook: Analyzing Its 9.65% Potential Upside

Bausch + Lomb Corporation (NYSE: BLCO), a venerable name in the healthcare sector with roots dating back to 1853, continues to capture investor interest with its..

Globus Medical, Inc. (GMED) Stock Analysis: Unveiling a 31.90% Potential Upside in the Healthcare Sector

Investors with an interest in the healthcare sector, particularly the medical devices industry, may find Globus Medical, Inc. (NYSE: GMED) worth considering. This Pennsylvania-based company, with..

Dr. Reddy’s Laboratories Ltd (RDY): Investor Outlook Reveals 14% Potential Upside in Healthcare Sector

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), an Indian pharmaceutical giant, stands as a compelling prospect for investors navigating the healthcare sector. With a market capitalization of..

Genmab A/S (GMAB) Stock Analysis: A 31.49% Potential Upside in the Biotech Sector

For investors eyeing the biotechnology sector, Genmab A/S (NASDAQ: GMAB) presents a compelling opportunity. With an impressive $17.72 billion market cap, this Danish biotech powerhouse is..

ADMA Biologics Inc (ADMA) Stock Analysis: A Look at Its 100.95% Potential Upside

As the healthcare sector continues to be a focal point for investors seeking growth opportunities, ADMA Biologics Inc (NASDAQ: ADMA) emerges as a noteworthy contender within..

Glaukos Corporation (GKOS) Stock Analysis: High Growth Prospects with a 16% Potential Upside

Glaukos Corporation (NYSE: GKOS), a prominent player in the medical devices sector focused on ophthalmic solutions, is currently capturing the attention of investors with its robust..

Repligen Corporation (RGEN) Investor Outlook: Exploring the 31.69% Potential Upside

Repligen Corporation (NASDAQ: RGEN), a prominent player in the healthcare sector, specializes in medical instruments and supplies. With a market capitalization of $7.96 billion, Repligen is..

Cytokinetics, Incorporated (CYTK) Stock Analysis: A 39.76% Potential Upside Sparks Investor Interest

Cytokinetics, Incorporated (NASDAQ: CYTK) is capturing the attention of investors with a compelling growth narrative in the biotechnology sector, coupled with an impressive potential upside of..

Encompass Health Corporation (EHC) Stock Analysis: A Strong Buy with 26.5% Potential Upside

Encompass Health Corporation (NYSE: EHC) stands as a formidable player in the healthcare sector, specifically within the medical care facilities industry. Operating primarily in the United..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds